GoAI
Get started
Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN

NYSEHealthcareMedical - Instruments & Supplies

Open in GoAI

Previous close

$22.60

+$0.25 · +1.12%

Aug 21, 4:00 PM ET

STVN company overview

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

70

Undervalued

Momentum

50

Neutral

Sentiment

48

Mixed

Risk resilience

53

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
IT
CEO
Franco Stevanato
Listed since
Jul 16, 2021
Employees
6,010

Market position

Day range

Current $22.60

52-week range

Current $22.60

Open
$22.21
Previous close
$22.35
Volume
253.61K
0.61× average
Average volume
413.26K
Average daily volume
Market cap
6.17B USD
Beta
0.74
Market reference 1
50-day average
$19.401
+16.49% above average
200-day average
$18.4316
+22.62% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.02B EUR
EV / EBITDA
17.38×
Earnings yield
2.87%
Free cash flow yield
0.46%

Profitability & efficiency

Return on equity
9.04%
Return on assets
5.28%
Return on invested capital
6.36%

Financial health

Current ratio
1.74×

Earnings

EPS beat rate
55%
6 beats, 4 misses, 1 met estimate
Average EPS surprise
+0.64%
11 comparable reports
Latest EPS result
0.16
Estimate 0.14 · Beat by 10.50%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.250.20.140.09Q1 '25MetQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 6, 2025: actual 0.2, estimate 0.2, surprise 0.00%, Met estimate. Q2 2025, reported May 8, 2025: actual 0.11, estimate 0.1, surprise +10.00%, Beat. Q3 2025, reported Aug 5, 2025: actual 0.12, estimate 0.11, surprise +9.09%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.16, estimate 0.14, surprise +14.29%, Beat. Q1 2026, reported Mar 4, 2026: actual 0.21, estimate 0.2, surprise +5.00%, Beat. Q2 2026, reported May 7, 2026: actual 0.13, estimate 0.12, surprise +8.33%, Beat. Q3 2026, reported Aug 4, 2026: actual 0.16, estimate 0.145, surprise +10.50%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.17, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates423.25M366.12M309M251.88MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 6, 2025: actual 342.33M USD, estimate 268.16M USD, surprise +27.66%, Beat. Q2 2025, reported May 8, 2025: actual 281.29M USD, estimate 301.6M USD, surprise -6.73%, Miss. Q3 2025, reported Aug 5, 2025: actual 329.73M USD, estimate 343.21M USD, surprise -3.93%, Miss. Q4 2025, reported Nov 6, 2025: actual 355.08M USD, estimate 385.49M USD, surprise -7.89%, Miss. Q1 2026, reported Mar 4, 2026: actual 406.97M USD, estimate 391.27M USD, surprise +4.01%, Beat. Q2 2026, reported May 7, 2026: actual 316.11M USD, estimate 310.47M USD, surprise +1.82%, Beat. Q3 2026, reported Aug 4, 2026: actual 344.9M USD, estimate 340.58M USD, surprise +1.27%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 375.31M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$32.00

41.59% upside
Past 12 months12-month forecast

Price history unavailable

High $32.00Average $32.00Low $32.00

STVN peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding STVN

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Biotechnology ETF logoiShares Biotechnology ETFIBB
Market value
8.28M
Weight
0.08%
AUM
10.75B USD
Expense ratio
0.44%
Price / 1D
$213.56+1.29%
State Street SPDR S&P Kensho New Economies Composite ETF logoState Street SPDR S&P Kensho New Economies Composite ETFKOMP
Market value
1.6M
Weight
0.06%
AUM
2.71B USD
Expense ratio
0.20%
Price / 1D
$69.24+0.92%
Acuitas Small Cap Active ETF logoAcuitas Small Cap Active ETFAIMS
Market value
645.21K
Weight
0.73%
AUM
74.33M USD
Expense ratio
0.75%
Price / 1D
$28.3937+0.94%
State Street SPDR US Small Cap Low Volatility Index ETF logoState Street SPDR US Small Cap Low Volatility Index ETFSMLV
Market value
416.29K
Weight
0.16%
AUM
257.64M USD
Expense ratio
0.12%
Price / 1D
$159.7+0.39%
Infrastructure Capital Small Cap Income ETF logoInfrastructure Capital Small Cap Income ETFSCAP
Market value
336.88K
Weight
1.65%
AUM
19.97M USD
Expense ratio
2.20%
Price / 1D
$39.21+0.72%
American Century Small Cap Growth Insights ETF logoAmerican Century Small Cap Growth Insights ETFACSG
Market value
100.37K
Weight
0.31%
AUM
32.84M USD
Expense ratio
0.49%
Price / 1D
$49.57+0.83%
First Eagle Small Cap Equity ETF logoFirst Eagle Small Cap Equity ETFFESC
Market value
12.52K
Weight
0.52%
AUM
2.18M USD
Expense ratio
0.85%
Price / 1D
$23.89680.00%

Continue in GoAI

Research STVN

research.disclaimer